An important reason for the high relapse rate in leukemia is the upregulation of antiapoptotic proteins (such as BCL‐2 and BCL‐xL), which prevents apoptosis and thereby promotes the survival of LSCs during treatment.175. This evidence concerns the gene BCL2 and leukemia.